Four Pharmacogenomic Variants Strongly Linked to Corticosteroid-Induced Avascular Necrosis in Children with Cancer.
Saved in:
| Title: | Four Pharmacogenomic Variants Strongly Linked to Corticosteroid-Induced Avascular Necrosis in Children with Cancer. |
|---|---|
| Authors: | Cordova-Delgado M; Division of Translational Therapeutics, Department of Pediatrics, Faculty of Medicine, University of British Columbia, Vancouver, Canada.; BC Children's Hospital Research Institute, Vancouver, Canada.; Pharmaceutical Outcomes Programme, British Columbia Children's Hospital, Vancouver, Canada., Scott EN; Division of Translational Therapeutics, Department of Pediatrics, Faculty of Medicine, University of British Columbia, Vancouver, Canada.; BC Children's Hospital Research Institute, Vancouver, Canada.; Department of Medical Genetics, Faculty of Medicine, University of British Columbia, Vancouver, Canada., Rassekh SR; BC Children's Hospital Research Institute, Vancouver, Canada.; Division of Oncology, Hematology and Bone Marrow Transplant, Department of Pediatrics, Faculty of Medicine, BC Children's Hospital and University of British Columbia, Vancouver, Canada., Loucks CM; Division of Translational Therapeutics, Department of Pediatrics, Faculty of Medicine, University of British Columbia, Vancouver, Canada.; BC Children's Hospital Research Institute, Vancouver, Canada.; Department of Anesthesiology, Pharmacology and Therapeutics, Faculty of Medicine, University of British Columbia, Vancouver, Canada., Chang WC; Division of Translational Therapeutics, Department of Pediatrics, Faculty of Medicine, University of British Columbia, Vancouver, Canada.; BC Children's Hospital Research Institute, Vancouver, Canada.; Pharmaceutical Outcomes Programme, British Columbia Children's Hospital, Vancouver, Canada., Raack EJ; BC Children's Hospital Research Institute, Vancouver, Canada.; Department of Medical Genetics, Faculty of Medicine, University of British Columbia, Vancouver, Canada., Trueman JN; Division of Translational Therapeutics, Department of Pediatrics, Faculty of Medicine, University of British Columbia, Vancouver, Canada.; BC Children's Hospital Research Institute, Vancouver, Canada., Ross CJD; BC Children's Hospital Research Institute, Vancouver, Canada.; Department of Medical Genetics, Faculty of Medicine, University of British Columbia, Vancouver, Canada.; Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, Canada., Carleton BC; Division of Translational Therapeutics, Department of Pediatrics, Faculty of Medicine, University of British Columbia, Vancouver, Canada.; BC Children's Hospital Research Institute, Vancouver, Canada.; Pharmaceutical Outcomes Programme, British Columbia Children's Hospital, Vancouver, Canada.; Department of Medical Genetics, Faculty of Medicine, University of British Columbia, Vancouver, Canada. |
| Corporate Authors: | Canadian Pharmacogenomics Network for Drug Safety Consortium |
| Source: | Journal of clinical pharmacology [J Clin Pharmacol] 2025 Dec; Vol. 65 (12), pp. 1844-1854. Date of Electronic Publication: 2025 Jul 25. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wiley Country of Publication: England NLM ID: 0366372 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1552-4604 (Electronic) Linking ISSN: 00912700 NLM ISO Abbreviation: J Clin Pharmacol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1552-4604 |
|---|---|
| DOI: | 10.1002/jcph.70084 |
